- Home
- »
- Medical Devices
- »
-
Endobronchial Ultrasound Biopsy Scopes Market Report, 2033GVR Report cover
Endobronchial Ultrasound Biopsy Scopes Market (2026 - 2033)
Size, Share & Trends Analysis Report By Product (Convex (CP-EBUS Scope), Radial (RP-EBUS Probe)), By Procedure (EBUS Scopes), By End-use (Hospitals, Ambulatory Surgical Centers (ASCs)), By Region, And Segment Forecasts
Market Size, 2025
$26.8MMarket Estimate, 2026
$28.8MMarket Forecast, 2033
$40.7MCAGR, 2026–2033
5.1%Endobronchial Ultrasound Biopsy Scopes Market Summary
The global endobronchial ultrasound biopsy scopes market size was valued at USD 26.8 million in 2025 and is projected to grow from USD 28.8 million in 2026 to USD 40.7 million by 2033, growing at a CAGR of 5.1% from 2026 to 2033. North America dominated the market in 2025, with a revenue share of 34.1%. This growth is attributed to the rising incidence of lung cancer and respiratory disorders, increased innovation in EBUS bronchoscopes, shift toward minimally invasive diagnostics, government-led lung cancer screening programs, and increasing replacement of conventional bronchoscopes with advanced EBUS scopes.
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,Download Free Sample Report
Key Market Trends & Insights
- By product: Linear EBUS (CP-EBUS) segment held the largest market share of 93.2% in 2025.
- By procedure: Linear EBUS (CP-EBUS) procedure segment accounted for the largest revenue share in 2025
- By end use: Hospitals segment dominated the market with a revenue share of 52.0% in 2025.
Regional Highlights
- Largest regional market: North America (34.1% revenue share, 2025)
- Fastest-growing regional market:Middle East & Africa (highest CAGR, 2026-2033)
- By country: The U.S. held the largest market share of North America in 2025.
Market Size & Forecast
- Market size in 2025: USD 26.8 Million
- Estimated market size in 2026: USD 28.8 Million
- Projected market size by 2033: USD 40.7 Million
- CAGR (2026-2033): 5.1%
Prism AI by Grand View Research Free to tryAsk a question about the endobronchial ultrasound biopsy scopes marketTry asking✓Every figure cited from GVR research Prefer the report? Download free sample →
To learn more about this report,Download Free Sample Report
Market Concentration & Characteristics
The degree of innovation in the endobronchial ultrasound (EBUS) biopsy scopes market is high, driven by advancements in bronchoscope design, ultrasound imaging, maneuverability, and ergonomic performance. Manufacturers are developing next-generation EBUS bronchoscopes with slimmer insertion tubes, improved angulation, enhanced visualization, and optimized distal-end designs to improve navigation through complex airway anatomies and support more efficient pulmonary diagnostic procedures. For instance, in May 2026, FUJIFILM Healthcare Americas launched the EB-710US, a balloon-less endobronchial ultrasound bronchoscope featuring 180° bending angulation, a 6.4 mm distal end, and a 5.9 mm insertion tube to improve maneuverability and visualization during bronchoscopic procedures.
The level of partnerships and collaboration activities in the endobronchial ultrasound biopsy scopes market is moderate to high, with manufacturers increasingly collaborating with hospitals, academic medical centers, and respiratory societies to accelerate product evaluation, generate clinical evidence, and enhance physician training. For instance, in November 2025, Olympus Corporation announced a partnership with the COPD Foundation to strengthen respiratory care through physician education, clinical research, and evidence generation for advanced pulmonary technologies, including endobronchial ultrasound solutions. The collaboration is intended to expand clinician engagement, support innovation in interventional pulmonology, and improve access to minimally invasive respiratory diagnostics.
To learn more about this report,Download Free Sample Report
“Olympus has long been a leader in providing medical technology solutions for interventional pulmonology, starting with our pioneering role in working with pulmonologists to develop the first endobronchial ultrasound bronchoscope, “With a strong Medical & Scientific affairs team dedicated to the respiratory field, Olympus will continue its important partnership with clinicians to identify and address unmet needs in respiratory care. Experienced and knowledgeable clinical practitioners and researchers like Drs. Gildea and Ötvös will ensure Olympus develops innovative medical devices while driving patient-focused value.”
- John de Csepel, MD, FACS, Chief Medical Officer at Olympus Corporation.
The regulatory authorities continue to strengthen requirements for medical device safety, quality, performance, and clinical validation, impacting the market. Regulations such as the U.S. FDA's medical device regulations and the European Union Medical Device Regulation (EU MDR) require manufacturers to demonstrate the safety, effectiveness, and reliability of EBUS bronchoscopes before commercialization. These requirements increase product development costs and regulatory approval timelines but improve product quality, strengthen clinician confidence, and support the adoption of advanced EBUS biopsy scopes across healthcare facilities.
The endobronchial ultrasound biopsy scopes market is expanding as key players such as Olympus Corporation, FUJIFILM Holdings Corporation, PENTAX Medical (a division of HOYA) strengthen their global presence through new product launches, expanded distribution networks, and investments in pulmonary diagnostic technologies. Companies are increasing their footprint across North America, Europe, and Asia-Pacific by collaborating with healthcare providers and expanding access to advanced EBUS bronchoscopes, supporting broader adoption in hospitals and specialized pulmonary care centers.
Analyst Perspective
The market for endobronchial ultrasound (EBUS) biopsy scopes is expanding rapidly, driven by the rising prevalence of lung cancer and respiratory disorders. Increased adoption of minimally invasive diagnostic procedures and broader screening programs are fueling this demand. Additionally, growing investments in healthcare infrastructure and the need for accurate disease staging support market growth. Manufacturers are actively innovating by developing next-generation scopes with enhanced imaging, improved maneuverability, and slimmer profiles. To capitalize on this demand, leading companies are expanding geographically, training physicians, and partnering strategically with healthcare institutions.
Product Insights
The convex (CP-EBUS Scope) segment accounted for the largest revenue market share of 93.2% in 2025, due to its ability to provide real-time ultrasound-guided needle aspiration of mediastinal and hilar lymph nodes. The integrated bronchoscope and ultrasound transducer enable accurate diagnosis and staging of lung cancer while supporting minimally invasive tissue sampling. Its widespread adoption in hospitals and specialized pulmonary centers, supported by established clinical guidelines and growing use in thoracic oncology, continues to drive demand for CP-EBUS systems.
The radial (RP-EBUS Probe) segment is expected grow at fastest CAGR during the forecast period from 2026 to 2033. This growth is driven by increasing use in the evaluation of peripheral pulmonary nodules and small lung lesions that are difficult to access with conventional bronchoscopy. The probe-based ultrasound system, used in combination with a standard bronchoscope, provides high-resolution imaging of peripheral airways and supports earlier diagnosis of suspicious lesions detected through expanding lung cancer screening programs. Continuous technological advancements and increasing adoption of minimally invasive pulmonary diagnostics are further supporting the growth of the RP-EBUS segment.
Procedures Insights
The linear EBUS (CP-EBUS) procedure segment growth is driven by the increasing prevalence of lung cancer, growing preference for minimally invasive diagnostic techniques, and widespread use of CP-EBUS for mediastinal lymph node evaluation and lung cancer staging. The increasing adoption of EBUS-guided procedures in hospitals and specialized pulmonary centers, coupled with advancements in bronchoscope design and ultrasound imaging, continues to support higher procedure volumes.
The radial probe EBUS (RP-EBUS) segment growth is driven by the increasing detection of peripheral pulmonary nodules through lung cancer screening programs and the rising demand for minimally invasive diagnosis of small peripheral lung lesions. The ability of RP-EBUS to improve visualization of difficult-to-reach peripheral airways, together with advancements in navigation technologies and guided bronchoscopy systems, is expected to accelerate procedure volumes across pulmonary care settings.
End-use Insights
The hospitals segment dominated the market with largest revenue share of 52.0%, in 2025. This is attributed to the high volume of pulmonary diagnostic procedures performed in hospitals, the availability of advanced bronchoscopy infrastructure, and the presence of skilled pulmonologists and thoracic specialists. Hospitals are the primary adopters of EBUS biopsy scopes due to increasing demand for minimally invasive lung cancer diagnosis and staging, supported by investments in advanced pulmonary endoscopy equipment. In addition, favorable reimbursement policies and the integration of advanced bronchoscopy technologies continue to strengthen the adoption of EBUS biopsy scopes in hospital settings.
To learn more about this report,Download Free Sample Report
The ambulatory surgical centers (ASCs) segment is expected to grow at fastest CAGR of 5.5% over the forecast period from 2026 to 2023. Growth is driven by the increasing shift toward outpatient pulmonary procedures, rising demand for minimally invasive diagnostics, and the expanding availability of advanced bronchoscopy services in ASCs. These facilities offer shorter procedure times, lower treatment costs, and faster patient recovery compared to inpatient settings. In addition, growing investments in advanced bronchoscopy infrastructure and increasing adoption of EBUS biopsy scopes are supporting the expansion of pulmonary diagnostic services in ambulatory surgical centers.
Regional Insights
North America dominated the market in 2025 with a revenue share of 34.1%. This dominance is driven by the high incidence of lung cancer, widespread adoption of minimally invasive pulmonary diagnostic procedures, well-established bronchoscopy infrastructure, and favorable reimbursement for EBUS-guided procedures. The presence of leading manufacturers such as Olympus Corporation, FUJIFILM Holdings Corporation, and PENTAX Medical, along with increasing investments in advanced pulmonary diagnostics, continues to support market growth.
To learn more about this report,Download Free Sample Report
U.S. Endobronchial Ultrasound Biopsy Scopes Market Trends
The U.S. endobronchial ultrasound biopsy scopes market dominated North America in 2025, due to the rising incidence of lung cancer, increasing adoption of EBUS-guided bronchoscopy for diagnosis and staging, and the presence of advanced pulmonary care centers. In addition, robust reimbursement support, ongoing technological advancements, and growing investments in minimally invasive pulmonary diagnostics are accelerating the adoption of EBUS biopsy scopes across healthcare facilities.
Furthermore, the growing burden of chronic respiratory diseases is increasing the demand for advanced bronchoscopic evaluation. According to the Centers for Disease Control and Prevention (CDC), approximately 4.3% of adults aged 18 years and over were living with COPD, emphysema, or chronic bronchitis in 2023. As the prevalence of respiratory diseases continues to rise, the need for early and accurate diagnosis is expected to increase, supporting greater adoption of minimally invasive procedures such as EBUS and driving demand for EBUS biopsy scopes over the forecast period.
Europe Endobronchial Ultrasound Biopsy Scopes Market Trends
The Europe endobronchial ultrasound biopsy scopes market is driven by the increasing adoption of minimally invasive bronchoscopy procedures, expanding lung cancer screening initiatives, and growing investments in pulmonary diagnostic infrastructure. Favorable regulatory support, well-established healthcare systems, and the increasing emphasis on early diagnosis of respiratory diseases are further contributing to market growth across the region.
The high prevalence of lung cancer is also driving demand for advanced diagnostic technologies such as EBUS biopsy scopes. For instance, according to Eurostat, 228,987 people died from lung cancer in Europe in 2022, accounting for 19.8% of all cancer-related deaths. This substantial disease burden is increasing the need for accurate and minimally invasive diagnostic procedures, thereby supporting the adoption of EBUS biopsy scopes across European healthcare facilities.
The endobronchial ultrasound biopsy scopes market in the UK is driven by the expansion of the NHS Lung Cancer Screening Program, increasing adoption of EBUS-guided diagnostic procedures, and growing investments in respiratory care services. The presence of specialized pulmonary centers and increasing focus on early lung cancer diagnosis continue to support market demand.
The endobronchial ultrasound biopsy scopes market in Germany is growing due to its advanced healthcare infrastructure, increasing adoption of minimally invasive pulmonary diagnostics, and strong presence of bronchoscopy equipment manufacturers. Rising investments in hospital modernization and thoracic oncology services are further supporting market growth.
Asia Pacific Endobronchial Ultrasound Biopsy Scopes Market Trends
Asia Pacific is expected to grow significantly over the forecast period from 2026 to 2033. Market growth is driven by the rising burden of lung cancer, improving healthcare infrastructure, increasing adoption of advanced bronchoscopy technologies, and expanding government initiatives for early cancer detection. Growing healthcare expenditure and increasing investments in pulmonary diagnostic facilities are further supporting market expansion.
The endobronchial ultrasound biopsy scopes market in Japan is witnessing significant growth due to its aging population, high incidence of lung cancer, and strong adoption of advanced endoscopic technologies. Continuous investments in medical device innovation and increasing use of minimally invasive pulmonary diagnostic procedures are encouraging the adoption of next-generation EBUS bronchoscopes.
The endobronchial ultrasound biopsy scopes market in China is witnessing strong growth, driven by the increasing incidence of lung cancer, rapid expansion of tertiary healthcare facilities, and growing adoption of advanced bronchoscopy technologies. Government initiatives to strengthen cancer diagnosis and healthcare infrastructure, along with increasing investments in pulmonary care, are supporting market growth across the country.
Latin America Endobronchial Ultrasound Biopsy Scopes Market Trends
The Latin America endobronchial ultrasound biopsy scopes market is driven by the increasing burden of respiratory diseases, improving access to advanced pulmonary diagnostics, and rising investments in healthcare infrastructure. Growing awareness of early lung cancer diagnosis and increasing adoption of minimally invasive bronchoscopy procedures are supporting market expansion across the region.
Middle East & Africa Endobronchial Ultrasound Biopsy Scopes Market Trends
The endobronchial ultrasound biopsy scopes market in the Middle East & Africa is expected to grow at fastest CAGR of 7.9% over the forecast period from 2026 to 2033. This is due to ongoing healthcare modernization, increasing investments in specialized respiratory care, and expanding access to advanced bronchoscopy services. Rising awareness of early lung cancer diagnosis and improving pulmonary diagnostic infrastructure are creating new opportunities for market growth.
Key Endobronchial Ultrasound Biopsy Scopes Company Insights
Key industry players are adopting various strategies, continuously innovating and introducing next-generation endobronchial ultrasound biopsy scopes with enhanced ultrasound imaging, improved maneuverability, ergonomic designs, and advanced visualization capabilities to strengthen their market position. Companies are focusing on improving bronchoscope performance, procedural efficiency, and compatibility with modern pulmonary endoscopy systems to support accurate diagnosis and staging of lung diseases. Strategic initiatives such as new product launches, regulatory approvals, physician training programs, geographic expansion, and collaborations with healthcare institutions.
Key Endobronchial Ultrasound Biopsy Scopes Companies
The following key companies have been profiled for this study on the endobronchial ultrasound biopsy scopes market.
-
Olympus Corporation
-
FUJIFILM Holdings Corporation
-
PENTAX Medical (a division of HOYA Group)
Recent Developments
-
In September 2024, FUJIFILM Holdings Corporation announced the compatibility of its ARIETTA 750 FF ENDO ultrasound system with several ultrasound endoscopes and a linear bronchoscope. This system features advanced technologies such as “eFocusing” for improved image clarity and “Carving Imaging” for enhanced visualization.
Endobronchial Ultrasound Biopsy ScopesMarket Report Scope
Report Attribute
Details
Market size in 2025
USD 26.8 million
Estimated market size in 2026
USD 28.8 million
Projected market size by 2033
USD 40.7 million
Growth rate
CAGR of 5.1% from 2026 to 2033
Actual data
2021 - 2025
Forecast period
2026 - 2033
Quantitative units
Market Value in USD million, procedure volume in thousand procedures, annual equipment sales and installed base (absolute number) and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Product, procedure, end-use, region
Regional scope
North America; Europe; Asia Pacific; Latin America; MEA
Country scope
U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; Norway; Denmark; Sweden; China; Japan; India; South Korea; Australia; Thailand; Brazil; Argentina; Saudi Arabia; South Africa; UAE; Kuwait
Key companies profiled
Olympus Corporation; FUJIFILM Holdings Corporation; PENTAX Medical (a division of HOYA Group)
Customization scope
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Endobronchial Ultrasound Biopsy Scopes Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global endobronchial ultrasound biopsy scopesmarket report based on product, procedures, end use and regions:
To learn more about this report,Download Free Sample Report
-
Product Outlook (Revenue in USD Million, Annual Equipment Sales Volume, Installed Base, 2021 - 2033)
-
Convex (CP-EBUS Scope)
-
Radial (RP-EBUS Probe)
-
-
Procedure Outlook (Number of Procedures in Thousand, 2021 - 2033)
-
EBUS Scopes
-
Convex-probe (Linear / CP-EBUS) Scopes
-
Lung Cancer Staging
-
Sarcoidosis/Others
-
-
Radial-probe (RP-EBUS) Scopes
-
-
-
End Use Outlook (Revenue, USD Million, 2021 - 2033)
-
Hospitals
-
Community Hospitals
-
Academic/Teaching Hospitals
-
Large Multispecialty Hospitals/Networks
-
-
Ambulatory Surgical Centers (ASCs)
-
Independent ASCs
-
Hospital-Affiliated ASCs
-
-
Specialty Clinics
-
-
Regional Outlook (Revenue, USD Million, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia
-
Thailand
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East and Africa (MEA)
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Research Methodology
The endobronchial ultrasound biopsy scopes market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each endobronchial ultrasound biopsy scopes segment quantified using the revenue-capture definitions in the table below.
Segment Definition
Segment- Product
Revenue Capture Definition
Linear EBUS (CP-EBUS)
Revenue generated from the sale of integrated convex probe endobronchial ultrasound (CP-EBUS) bronchoscopes that combine a bronchoscope with a real-time ultrasound transducer for mediastinal and hilar lymph node imaging and pulmonary diagnostic procedures.
Radial Probe EBUS (RP-EBUS)
Revenue generated from the sale of radial probe endobronchial ultrasound (RP-EBUS) systems, including ultrasound probes used in combination with compatible bronchoscopes for imaging and evaluation of peripheral pulmonary lesions and lung nodules.
Segment- Procedure
Revenue Capture Definition
Convex-Probe (Linear / CP-EBUS) Scopes - By Indication
Procedure volume generated from the use of convex probe (linear) EBUS bronchoscopes for pulmonary diagnostic procedures, including lung cancer staging, mediastinal lymph node assessment, and other clinical indications.
Procedures by indication:
- Lung Cancer Staging
- Sarcoidosis/Others
Radial-Probe (RP-EBUS) Scopes
Procedure volume generated from the use of radial probe EBUS systems for the evaluation and diagnosis of peripheral pulmonary nodules, peripheral lung lesions, and other respiratory conditions.
Segment- End-use
Revenue Capture Definition
Hospitals
Revenue generated from the sale of EBUS biopsy scopes to public and private hospitals performing pulmonary diagnostic, interventional bronchoscopy, and thoracic oncology procedures.
This segments also includes:- Community Hospitals
- Academic/Teaching Hospitals
- Large Multispecialty Hospitals/Networks
Ambulatory Surgical Centers (ASCs)
Revenue generated from the sale of EBUS biopsy scopes to ambulatory surgical centers providing outpatient bronchoscopy and minimally invasive pulmonary diagnostic procedures.
This segments also includes:
- Independent ASCs
- Hospital-Affiliated ASCs
Specialty Clinics
Revenue generated from the sale of EBUS biopsy scopes to specialty pulmonary, respiratory, and thoracic care clinics performing diagnostic bronchoscopy, lung cancer evaluation, and other minimally invasive pulmonary procedures.
To learn more about this report,Download Free Sample Report
Delivered Customizations
This report has been delivered with the following In-depth customizations
Client Request
Customization Delivered
Value Adds
EBUS Scopes Installed Base & Procedure Volume Analysis
Comprehensive analysis of EBUS biopsy scopes installed base (absolute number), and procedure volume analysis by scope type, including Convex-Probe (Linear/CP-EBUS) and Radial-Probe (RP-EBUS), with indication-wise procedure estimates for Lung Cancer Staging and Sarcoidosis/Others.
Helps assess equipment utilization, replacement opportunities, procedure demand trends, forecast future scope requirements, and identify high-growth application areas for strategic planning.
Regional Company Market Share Analysis (Product Level)
Detailed regional market share analysis of leading EBUS biopsy scope manufacturers by product type across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, including competitive positioning and regional presence.
Enables benchmarking of regional competitors, identification of market leaders and whitespace opportunities, and supports regional expansion, product positioning, and competitive strategy development.
Country-Level Company Market Share Analysis
Detailed company market share analysis across 9 key countries (U.S. Germany, UK France, China, Japan India, Brazil, Saudi Arabia) including product-level market share, competitive positioning, regional presence, distribution network assessment, and strategic initiatives of leading EBUS biopsy scope manufacturers.
Enables benchmarking of competitors at the country level, identifies market leaders and whitespace opportunities, supports country-specific expansion strategies, and helps optimize sales, distribution, and investment decisions across key markets.
Technology & Regulatory Overview
In-depth assessment of technological advancements in EBUS biopsy scopes, including innovations in bronchoscope design, ultrasound imaging, and scope maneuverability, along with an overview of key regulatory frameworks such as U.S. FDA and EU MDR governing product approvals and commercialization.
Helps understand the technology landscape, evaluate regulatory requirements, reduce compliance risks, and support product development and market entry strategies across global markets.
Frequently Asked Questions About This Report
The global endobronchial ultrasound biopsy scopes market is expected to grow at a compound annual growth rate of 5.1% from 2026 to 2033 to reach USD 40.7 million by 2023.
Which product segment accounted for the largest endobronchial ultrasound biopsy scopes market share?The linear EBUS (CP-EBUS) segment held the largest market share of 93.2% in 2025.
North America dominated the endobronchial ultrasound biopsy scopes market with a share of 34.1% in 2025
Key factors that are driving the market growth include the rising incidence of lung cancer and respiratory disorders, increased innovation in EBUS bronchoscopes, the shift toward minimally invasive diagnostics, government-led lung cancer screening programs, and the increasing replacement of conventional bronchoscopes with advanced EBUS scopes.
Some key players operating in the endobronchial ultrasound biopsy scopes market include Olympus Corporation, FUJIFILM Holdings Corporation, PENTAX Medical (a division of HOYA Group)
Which end-use segment accounted for the largest endobronchial ultrasound biopsy scopes market share?The hospitals segment dominated the market with a revenue share of 52.0% in 2025.
Asia Pacific is expected to grow at the fastest CAGR of 14.0% from 2026 to 2033
The global endobronchial ultrasound biopsy scopes market size was valued at USD 26.8 million in 2025 and is estimated at USD 28.8 million in 2026.
About the Author(s)
Medical Devices Research Team
Healthcare · Medical DevicesThis report was authored by the medical devices research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the medical devices segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.